Severe nosebleeds more common with hypertension, finds a new
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
High blood pressure was linked to a higher risk and severity of nosebleeds, a population-based study showed.

In this retrospective cohort study, a hypertension cohort and comparison cohort were built using the Korean National Health Insurance Service. The hypertension cohort comprised 35749 patients with a record of 3 or more prescriptions of antihypertensive medication and a diagnosis of hypertension. Patients with other diseases associated with epistaxis, such as sinonasal tumors, facial trauma, bleeding tendency, and coagulation disorder, as well as those taking anticoagulant medications, were excluded.

-- Among the 35749 patients in the hypertension cohort, the incidence rate (IR) of epistaxis was 32.97 per 10000 persons; among the 35749 individuals in the comparison cohort, the IR of epistaxis was 22.76 per 10000 persons.
-- The IR of recurrent epistaxis was 1.96 per 10000 persons in the hypertension cohort and 1.59 per 10000 persons in the nonhypertension cohort.
-- Patients with hypertension who experienced epistaxis were more likely to use the emergency department and receive posterior nasal packing compared with the comparison cohort.

Conclusively, This study suggests that patients with hypertension had an increased risk of epistaxis requiring hospital visits. In addition, epistaxis in patients with hypertension appeared to need more emergency department visits and require more posterior nasal packing procedures compared with patients without hypertension. Medical counseling about epistaxis is advisable for individuals with hypertension, and the presence of hypertension should be considered in managing nasal bleedings.